ADVANCED HODGKIN LYMPHOMA IN THE EAST OF ENGLAND CANCER NETWORK: A 10 YEAR COMPARATIVE ANALYSIS OF OUTCOMES FOR ABVD AND ESCALATED BEACOPP TREATED PATIENTS AGED 16-59

被引：0
|
作者：
Collins, A. [1 ]
Fowler, A. [2 ]
Karanth, M. [3 ]
Saha, C. [4 ]
Russel, J. [5 ]
Shyamsundar, V. [1 ]
Docherty, S. [6 ]
Maw, K. [7 ]
Padayatty, J. [4 ]
Hodson, A. [5 ]
Wimperis, J. [6 ]
Sadullah, S. [7 ]
Grigoropoulos, N. [1 ]
Uttenthal, B. [1 ]
Follows, G. [1 ]
机构：
[1] Cambridge Univ Hosp, Cambridge, England
[2] Peterborough Hosp, Peterborough, Cambs, England
[3] West Suffolk Hosp, Bury St Edmunds, Suffolk, England
[4] Kings Lynn Hosp, Kings Lynn, England
[5] Ipswich Hosp, Ipswich, Suffolk, England
[6] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[7] James Paget Univ Hosp, Great Yarmouth, Norfolk, England
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P006
引用
收藏
页码：22 / 22
页数：1
相关论文
共 11 条
  • [1] ADVANCED HODGKIN LYMPHOMA IN THE EAST OF ENGLAND CANCER NETWORK: A 10-YEAR COMPARATIVE ANALYSIS OF OUTCOMES FOR ABVD AND ESCALATED-BEACOPP TREATED PATIENTS AGED 16-59
    Russell, J.
    Collins, A.
    Fowler, A.
    Karanth, M.
    Saha, C.
    Shyamsundar, V.
    Docherty, S.
    Maw, K.
    Padayatty, J.
    Hodson, A.
    Wimperis, J.
    Sadullah, S.
    Grigoropoulos, N.
    Uttenthal, B.
    Follows, G.
    HAEMATOLOGICA, 2017, 102 : 82 - 82
  • [2] Advanced-Stage Hodgkin Lymphoma in the East of England Cancer Network: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPP in the Non-Trial Setting Compared with Age-Matched Patients Treated in the Multinational RATHL Trial
    Russell, James
    Collins, Angela
    Fowler, Alexis
    Karanth, Mamatha
    Lentell, Isabel
    Saha, Chandan
    Docherty, Suzanne
    Padayatty, Joseph
    Maw, Kyaw
    Cooke, Lisa
    Hodson, Andrew
    Shah, Nimish
    Sadullah, Shalal
    Grigoropoulos, Nicholas
    Qian, Wendi
    Kirkwood, Amy A.
    Uttenthal, Benjamin J.
    Johnson, Peter
    Follows, George A.
    BLOOD, 2017, 130
  • [3] Advanced-Stage Hodgkin Lymphoma in the East of England: A 10-Year Comparative Analysis of Outcomes for Patients Treated with ABVD or Escalated BEACOPP in the Non-Trial Setting Compared with Age-Matched Patients in the Multinational RATHL Trial
    Russell, J.
    Collins, A.
    Fowler, A.
    Karanth, M.
    Saha, C.
    Lentell, I.
    Docherty, S.
    Padayatty, J.
    Maw, K.
    Cooke, L.
    Hodson, A.
    Shah, N.
    Sadullah, S.
    Grigoropoulos, N.
    Qian, W.
    Kirkwood, A.
    Uttenthal, B.
    Johnson, P.
    Follows, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 76 - 77
  • [4] A 10-year analysis of outcomes for advanced-stage Hodgkin lymphoma comparing extended follow-up of the multinational RATHL trial with real-world patients treated with ABVD or escalated BEACOPP in the East of England
    Russell, J.
    Collins, A.
    Fowler, A.
    Karanth, M.
    Saha, C.
    Docherty, S.
    Padayatty, J.
    Maw, K.
    Lentell, I.
    Cooke, L.
    Hodson, A.
    Shah, N.
    Sadullah, S.
    Grigoropoulos, N.
    Qian, W.
    Kirkwood, A.
    Uttenthal, B.
    Johnson, P.
    Follows, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 30 - 30
  • [5] Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial
    James Russell
    Angela Collins
    Alexis Fowler
    Mamatha Karanth
    Chandan Saha
    Suzanne Docherty
    Joseph Padayatty
    Kyaw Maw
    Isabel Lentell
    Lisa Cooke
    Andrew Hodson
    Nimish Shah
    Shalal Sadullah
    Nicholas Grigoropoulos
    Wendi Qian
    Amy A. Kirkwood
    Benjamin J. Uttenthal
    Peter Johnson
    George A. Follows
    Annals of Hematology, 2021, 100 : 1049 - 1058
  • [6] Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial
    Russell, James
    Collins, Angela
    Fowler, Alexis
    Karanth, Mamatha
    Saha, Chandan
    Docherty, Suzanne
    Padayatty, Joseph
    Maw, Kyaw
    Lentell, Isabel
    Cooke, Lisa
    Hodson, Andrew
    Shah, Nimish
    Sadullah, Shalal
    Grigoropoulos, Nicholas
    Qian, Wendi
    Kirkwood, Amy A.
    Uttenthal, Benjamin J.
    Johnson, Peter
    Follows, George A.
    ANNALS OF HEMATOLOGY, 2021, 100 (04) : 1049 - 1058
  • [7] A RETROSPECTIVE ANALYSIS OF FERTILITY IN FEMALE PATIENTS WITH ADVANCED STAGES OF HODGKIN LYMPHOMA TREATED WITH BEACOPP ESCALATED CHEMOTHERAPY (20 YEAR EXPERIENCE OF A SINGLE CENTRE)
    Markova, J.
    Mocikova, H.
    Gaherova, L'
    Jancarkova, T.
    Vernerova, Z.
    Dedeckova, K.
    Kozak, T.
    HAEMATOLOGICA, 2016, 101 : 67 - 67
  • [8] Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial
    Rodriguez-Romo, Laura N.
    Meyer, Ralph
    Pater, Joseph L.
    Sussman, Jonathan
    Zhang, Siwei
    Hongbo, Lui
    Winter, Jane N.
    Vuong, Te
    Blahey, Walter
    Mulroy, Liam
    Shepherd, Lois E.
    Djurfeldt, Marina S.
    Chen, Bingshu E.
    Hay, Annette E.
    BLOOD, 2017, 130
  • [9] Survival outcomes of east Asian patients with advanced non-small cell lung cancer treated with first-line EGFR tyrosine kinase inhibitors: A network meta-analysis of real-world evidence
    Chang, Huang-Chih
    Huang, Kuo-Tung
    Tseng, Chia-Cheng
    Chen, Yu-Mu
    Lai, Chien-Hao
    Chang, Yu-Ping
    Chen, Yung-Che
    Chuang, Hung-Yi
    Wang, Chin-Chou
    THORACIC CANCER, 2023, 14 (32) : 3217 - 3225
  • [10] Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta-analysis of real-world survival outcomes of East Asian patients with advanced non-small cell lung cancer treated with first-line EGFR-TKIs
    Chang, Huang-Chih
    Wang, Chin-Chou
    Tseng, Chia-Cheng
    Huang, Kuo-Tung
    Chen, Yu-Mu
    Chang, Yu-Ping
    Lai, Chien-Hao
    Fang, Wen-Feng
    Lin, Meng-Chih
    Chuang, Hung-Yi
    THORACIC CANCER, 2023, 14 (32) : 3208 - 3216
12